Cantargia: Europapatent inom hematologi kvarstår

Research Note

2018-01-23

16:12

Cantargia meddelade i dag att det Europeiska patentverket även avfärdat oppositionen mot patent kring hematologiska cancerformer.

MS

Mathias Spinnars

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.